HCR 72·LA·house
HEALTH SERVICES: Memorialize the United States Congress to research treatment methods for Acute Myeloid Leukemia
AdoptedFiled Apr 20, 2026
Sponsor: Beau Beaullieu (R)
Latest Action
Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
May 28, 2026
Summary
The concurrent resolution asks the U.S. Congress, NIH, NCI, and HHS to prioritize AML research, clinical trials, and new therapies, naming the effort the “Jonas A. Feeley Act.” It is intended to benefit patients with AML and their families, including veterans who may face higher risk, by calling for faster federal action on this aggressive blood cancer.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HCR 72 changes status, plus AI-powered summaries and stage predictions.
Sign up free